» Articles » PMID: 34102029

Excipient Knowledgebase: Development of a Comprehensive Tool for Understanding the Disposition and Interaction Potential of Common Excipients

Overview
Publisher Wiley
Specialty Pharmacology
Date 2021 Jun 8
PMID 34102029
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Although the use of excipients is widespread, a thorough understanding of the drug interaction potential of these compounds remains a frequent topic of current research. Not only can excipients alter the disposition of coformulated drugs, but it is likely that these effects on co-administered drugs can reach to clinical significance leading to potential adverse effects or loss of efficacy. These risks can be evaluated through use of in silico methods of mechanistic modeling, including approaches, such as population pharmacokinetic (PK) and physiologically-based PK modeling, which require a comprehensive understanding of the compounds to ensure accurate predictions. We established a knowledgebase of the available compound (or substance) and interaction-specific parameters with the goal of providing a single source of physiochemical, in vitro, and clinical PK and interaction data of commonly used excipients. To illustrate the utility of this knowledgebase, a model for cremophor EL was developed and used to hypothesize the potential for CYP3A- and P-gp-based interactions as a proof of concept.

Citing Articles

A Critical Overview of the Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption.

Martinez M, Sinko B, Wu F, Flanagan T, Borbas E, Tsakalozou E AAPS J. 2022; 24(3):60.

PMID: 35501614 DOI: 10.1208/s12248-022-00711-3.


A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development.

Martinez M, Wu F, Sinko B, Brayden D, Grass M, Kesisoglou F AAPS J. 2022; 24(3):61.

PMID: 35501528 DOI: 10.1208/s12248-022-00713-1.


Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients.

McFeely S, Yu J, Wang Y, Wu C, Ragueneau-Majlessi I CPT Pharmacometrics Syst Pharmacol. 2021; 10(8):953-961.

PMID: 34102029 PMC: 8376134. DOI: 10.1002/psp4.12668.

References
1.
Zou L, Pottel J, Khuri N, Ngo H, Ni Z, Tsakalozou E . Interactions of Oral Molecular Excipients with Breast Cancer Resistance Protein, BCRP. Mol Pharm. 2020; 17(3):748-756. PMC: 8177814. DOI: 10.1021/acs.molpharmaceut.9b00658. View

2.
Yeung C, Yoshida K, Kusama M, Zhang H, Ragueneau-Majlessi I, Argon S . Organ Impairment-Drug-Drug Interaction Database: A Tool for Evaluating the Impact of Renal or Hepatic Impairment and Pharmacologic Inhibition on the Systemic Exposure of Drugs. CPT Pharmacometrics Syst Pharmacol. 2015; 4(8):489-94. PMC: 4562165. DOI: 10.1002/psp4.55. View

3.
Tomaru A, Takeda-Morishita M, Maeda K, Banba H, Takayama K, Kumagai Y . Effects of Cremophor EL on the absorption of orally administered saquinavir and fexofenadine in healthy subjects. Drug Metab Pharmacokinet. 2015; 30(3):221-6. DOI: 10.1016/j.dmpk.2015.01.002. View

4.
McFeely S, Yu J, Wang Y, Wu C, Ragueneau-Majlessi I . Excipient knowledgebase: Development of a comprehensive tool for understanding the disposition and interaction potential of common excipients. CPT Pharmacometrics Syst Pharmacol. 2021; 10(8):953-961. PMC: 8376134. DOI: 10.1002/psp4.12668. View

5.
Woodcock D, Linsenmeyer M, Chojnowski G, Kriegler A, Nink V, Webster L . Reversal of multidrug resistance by surfactants. Br J Cancer. 1992; 66(1):62-8. PMC: 1977900. DOI: 10.1038/bjc.1992.217. View